Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.3%
- Check8 days agoChange DetectedThe page has been updated to reflect a new study timeline, extending the duration of treatment and evaluation from a maximum of 51 months to 62 months and 18 days. Additionally, the description of the study's aim has been clarified.SummaryDifference2%
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.